NFATC3 and cardiac hypertrophy: In Fig 3G, 3H and 3I we can see that both proteins involved in this pathway, NFATc3 (F(3,16) = 2.22, p = 0.05) and GATA-4 (F(3,15) = 1.60, p = 0.05), were higher in the PSD96 group compared to C group, suggesting pathologic cardiac hypertrophy.